In summary, we show that HAUS6 upregulation is associated with shorter survival of CRC patients and increased cell viability in cultured CRC cells, while HAUS6 knockdown inhibits tumor growth and enhances 5-FU treatment by activating the p53/p21 pathway. The gene discussed is TP53; the disease is neoplasm.